Owl Capital

Owl Capital

Signal active

Investment Firm

Overview

N/A

Highlights

Founded

2019

Industry

Financial Services

Employees

1-10

Investment

3

Lead Investment

0

Exits

undefined

Stages

Seed, Early Stage Venture

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

Owl Capital, established in 2019 and headquartered in United States, North America., specializes in Seed, Early Stage Venture investments across Biotechnology, Health Care, Biopharma, Financial Services, Venture Capital, Finance, Funding Platform, Financial Exchanges, Content, Podcast. Their recent investments include Deciduous Therapeutics, Bold Capital Partners, Healthspan Capital, Humboldt Fund, Lemonada Media. The highest investment round they participated in was $6.6B. Among their most notable exits are Deciduous Therapeutics and Bold Capital Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Jennifer Fonstad

Jennifer Fonstad

Managing Partner

Investment portfolio

Owl Capital has made 3 investments. Their most recent investment was on Dec 31, 2022, when Deciduous Therapeutics raised $10.0M.

Owl Capital has made 2 diversity investments. Their most recent diversity investment was on Jan 27, 2022, when Lemonada Media raised $8.0M.

investments

3

Diversity investments

2

Lead investments

0

Number of exits

undefined

Investments

3

Annouced DateOrganization NameIndustryMoney Raised
Apr 21, 2021
Welcome Tech Welcome Tech
Information Services35.0M
Jan 27, 2022
Lemonada Media Lemonada Media
Content8.0M
Dec 31, 2022
Deciduous Therapeutics Deciduous Therapeutics
Biotechnology10.0M

Exits

0

Funding Timeline

Funding rounds

3

Investors

0

Funds

0

Funding Rounds

3

Owl Capital has raised 3 rounds. Their latest funding was raised on Dec 31, 2022 from a Seed Round - Deciduous Therapeutics round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Apr 21, 2021
Series B - Welcome Tech Series B - Welcome Tech
-35.0M-
Jan 27, 2022
Series A - Lemonada Media Series A - Lemonada Media
-8.0M-
Dec 31, 2022
Seed Round - Deciduous Therapeutics Seed Round - Deciduous Therapeutics
-10.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.